WPI Watson Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : WPI Watson Pharmaceuticals

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: chengchung chang who wrote (39)	4/6/1999 7:09:00 PM
From: Zebra 365	Read Replies (2) of 61

Recalls are just rumor. S&P 500 is a fact. Now WPI is a "Must Buy" for S&P 500 Index funds. NEW YORK--(BUSINESS WIRE)--April 6, 1999--Standard & Poor's Financial Information Services will make the following changes in the S&P 500 and S&P MidCap 400 after the close of trading on Friday, April 9, 1999. S&P MidCap 400 component Watson Pharmaceuticals (WPI) will replace Aeroquip-Vickers Inc. (ANV) in the S&P 500 Index. Watson Pharmaceuticals is engaged in the development, manufacture and sale of proprietary and off-patent pharmaceutical products. The company, headquartered in Corona, California, will be added to the S&P 500 Health Care (Drugs-Generic & Other) industry group. Zebra

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next